"/> Novus Biologicals™ Peptide bloquant d’anticorps EG… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps EGLN1/PHD2

Réf. : BL-RE-045935Réf. fabricant : 18088565 0.05 mg
131,69 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
54583
Espèces
Mouse
Contenu et stockage
Store at -80 C. Avoid freeze-thaw cycles.
Formule
Peptide dissolved in dH2O. Contains no BSA.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NB100-2219. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A peptide to EGLN1. The EGLN1/PHD2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-045935
Réf. fabricant18088565
Gene ID (Entrez)54583
EspècesMouse
Contenu et stockageStore at -80 C. Avoid freeze-thaw cycles.
FormulePeptide dissolved in dH2O. Contains no BSA.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NB100-2219. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneC1orf12HPH2, EC 1.14.11, EC 1.14.11.-, ECYT3, egl nine homolog 1, egl nine homolog 1 (C. elegans), egl nine-like protein 1, HIF prolyl hydroxylase 2, HIF-PH2, HIFPH2 EGL nine (C.elegans) homolog 1, HIF-prolyl hydroxylase 2, HPH-2, Hypoxia-inducible factor prolyl hydroxylase 2, PHD2SM20, Prolyl hydroxylase domain-containing protein 2, SM-20, zinc finger MYND domain-containing protein 6, ZMYND6DKFZp761F179
Symbole de gène(s)EGLN1
Type de produitEGLN1/PHD2
Quantité0.05 mg
État réglementaireRUO - research use only
Une question, une configuration particulière ?
Contactez-nous pour un devis.